IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

Trump Announces New Drug Pricing Deals

The Trump administration has announced new drug pricing agreements with several pharmaceutical companies and smaller biotechs. Participating firms will offer medications to state Medicaid programs at lower prices, though specific savings remain unclear.

Xurve View
Insights:
U.S. Secretary of Commerce Howard Lutnick, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and U.S. Center for Medicare & Medicaid Services Administrator Dr. Mehmet Oz stand behind U.S. President Donald Trump in the Oval Office

United States President Donald Trump secured new drug-pricing agreements with six international pharmaceutical companies on Monday afternoon. The deals aim to lower prescription costs for Medicaid participants nationwide. Administration officials hope to curb healthcare spending before upcoming congressional elections.
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.